ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
contrapuntal
|
1.3K |
653K |
6 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
1.3K
|
653K
|
6
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
contrapuntal
|
1.3K |
653K |
3 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
1.3K
|
653K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
contrapuntal
|
190 |
65K |
3 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
190
|
65K
|
3
|
|
ASX - By Stock
|
KCN |
Re:
Ann: Green Light for Plant 1 at the Chatree Gold Mine
|
|
contrapuntal
|
168 |
60K |
8 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
168
|
60K
|
8
|
|
ASX - By Stock
|
KCN |
Re:
Ann: Green Light for Plant 1 at the Chatree Gold Mine
|
|
contrapuntal
|
168 |
60K |
3 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
168
|
60K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
contrapuntal
|
73 |
24K |
11 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
73
|
24K
|
11
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix to Acquire ARTMS (Isotope Production Platform)
|
|
contrapuntal
|
43 |
18K |
2 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
43
|
18K
|
2
|
|
ASX - By Stock
|
KCN |
Re:
Ann: Significant Gold Exploration Results in Thailand
|
|
contrapuntal
|
26 |
11K |
3 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
26
|
11K
|
3
|
|
ASX - By Stock
|
KCN |
Re:
Who else is coming to the AGM?
|
|
contrapuntal
|
15 |
6.2K |
5 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
15
|
6.2K
|
5
|
|
ASX - By Stock
|
KCN |
Re:
Ann: IMARC Presentation
|
|
contrapuntal
|
90 |
36K |
4 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
90
|
36K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
contrapuntal
|
1.3K |
653K |
6 |
19/11/23 |
19/11/23 |
ASX - By Stock
|
1.3K
|
653K
|
6
|
|
ASX - By Stock
|
KCN |
Re:
Ann: Chatree Gold Mine Update
|
|
contrapuntal
|
47 |
19K |
15 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
47
|
19K
|
15
|
|
ASX - By Stock
|
KCN |
Re:
Ann: IMARC Presentation
|
|
contrapuntal
|
90 |
36K |
4 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
90
|
36K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
PSMA-Targeting Alpha Emitter via Antibody Delivery for Prostate Cancer: Phase I 225Ac-J591
|
|
contrapuntal
|
4 |
1.9K |
9 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
4
|
1.9K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
contrapuntal
|
138 |
53K |
2 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
138
|
53K
|
2
|
|
ASX - By Stock
|
TLX |
PSMA-Targeting Alpha Emitter via Antibody Delivery for Prostate Cancer: Phase I 225Ac-J591
|
|
contrapuntal
|
4 |
1.9K |
4 |
05/11/23 |
05/11/23 |
ASX - By Stock
|
4
|
1.9K
|
4
|
|
ASX - By Stock
|
TLX |
Long-Term Nephrotoxicity of 177Lu-PSMA Radioligand Therapy
|
|
contrapuntal
|
0 |
466 |
11 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
0
|
466
|
11
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
contrapuntal
|
138 |
53K |
17 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
138
|
53K
|
17
|
|
ASX - By Stock
|
KCN |
Re:
Goodbye $1.20
|
|
contrapuntal
|
248 |
81K |
7 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
248
|
81K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
contrapuntal
|
138 |
53K |
6 |
29/10/23 |
29/10/23 |
ASX - By Stock
|
138
|
53K
|
6
|
|
ASX - By Stock
|
KCN |
Re:
Sep23 quarter predictions
|
|
contrapuntal
|
17 |
6.1K |
4 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
17
|
6.1K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 Positive Interim Readout
|
|
contrapuntal
|
34 |
18K |
9 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
34
|
18K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
contrapuntal
|
138 |
53K |
5 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
138
|
53K
|
5
|
|
ASX - By Stock
|
KCN |
Re:
Sep23 quarter predictions
|
|
contrapuntal
|
17 |
6.1K |
4 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
17
|
6.1K
|
4
|
|
ASX - By Stock
|
KCN |
Re:
Coppo small cap comments
|
|
contrapuntal
|
11 |
3.9K |
4 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
11
|
3.9K
|
4
|
|
ASX - By Stock
|
KCN |
Re:
$4 Party is coming soon?
|
|
contrapuntal
|
302 |
149K |
4 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
302
|
149K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Competition
|
|
contrapuntal
|
254 |
117K |
5 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
254
|
117K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Competition
|
|
contrapuntal
|
254 |
117K |
5 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
254
|
117K
|
5
|
|
ASX - By Stock
|
KCN |
Re:
Ann: Mining and Near-Surface Grade Control Drilling Update
|
|
contrapuntal
|
62 |
21K |
12 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
62
|
21K
|
12
|
|
ASX - By Stock
|
TLX |
Re:
Ann: 1H 2023 Results Presentation
|
|
contrapuntal
|
102 |
30K |
12 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
102
|
30K
|
12
|
|
ASX - By Stock
|
KCN |
Re:
General discussion
|
|
contrapuntal
|
5.2K |
1.9M |
17 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
5.2K
|
1.9M
|
17
|
|
ASX - By Stock
|
TLX |
Re:
Competition
|
|
contrapuntal
|
254 |
117K |
14 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
254
|
117K
|
14
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
contrapuntal
|
1.3K |
653K |
2 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
1.3K
|
653K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
A collaboration with Starpharna
|
|
contrapuntal
|
15 |
7.0K |
1 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
15
|
7.0K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
A collaboration with Starpharna
|
|
contrapuntal
|
15 |
7.0K |
5 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
15
|
7.0K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
12 month price targets
|
|
contrapuntal
|
29 |
13K |
10 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
29
|
13K
|
10
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Activities Report and Appendix 4C - June 2023 Quarter
|
|
contrapuntal
|
52 |
24K |
5 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
52
|
24K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
contrapuntal
|
1.5K |
600K |
2 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
1.5K
|
600K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Notification of upcoming quarterly results and investor call
|
|
contrapuntal
|
69 |
24K |
2 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
69
|
24K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Notification of upcoming quarterly results and investor call
|
|
contrapuntal
|
69 |
24K |
3 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
69
|
24K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Notification of upcoming quarterly results and investor call
|
|
contrapuntal
|
69 |
24K |
3 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
69
|
24K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Notification of upcoming quarterly results and investor call
|
|
contrapuntal
|
69 |
24K |
3 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
69
|
24K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Notification of upcoming quarterly results and investor call
|
|
contrapuntal
|
69 |
24K |
10 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
69
|
24K
|
10
|
|
ASX - By Stock
|
TLX |
Re:
Primary 2 Trial - Using PSMA PET to avoid unnecessary biopsies
|
|
contrapuntal
|
2 |
1.4K |
8 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
2
|
1.4K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Lightpoint Acquisition to Expand Telix Urologic Pipeline
|
|
contrapuntal
|
20 |
8.7K |
3 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
20
|
8.7K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Hello
|
|
contrapuntal
|
16 |
4.9K |
1 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
16
|
4.9K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Competition
|
|
contrapuntal
|
254 |
117K |
4 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
254
|
117K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
New paper on expanded indication for PSMA PET
|
|
contrapuntal
|
6 |
3.8K |
8 |
28/05/23 |
28/05/23 |
ASX - By Stock
|
6
|
3.8K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
contrapuntal
|
1.5K |
600K |
7 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
1.5K
|
600K
|
7
|
|
ASX - By Stock
|
KCN |
Re:
General discussion
|
|
contrapuntal
|
5.2K |
1.9M |
6 |
12/05/23 |
12/05/23 |
ASX - By Stock
|
5.2K
|
1.9M
|
6
|
|